Our results would potentially prompt improved awareness of semaglutide-related toxicities and provide valuable references for healthcare professionals to mitigate the risk of gastrointestinal AEs by post-marketing safety assessments
To prevent dehydration while taking semaglutide, its important to stay hydrated by drinking plenty of fluids throughout the day
This includes looking for signs of inflammation, dryness, open sores, or infection
December 2, 2024: Ozempic and Other GLP-1 Lawsuits Reach 1,300 Active Plaintiffs As of December 2, 2024, there are 1,300 pending lawsuits in the consolidated federal lawsuits against manufacturers of GLP-1 drugs such as Ozempic, which is manufactured by Novo Nordisk
Two GLP-1 RAs have shown cardiovascular benefits in cardiovascular outcome trials
There is currently no official NICE guidance recommending routine UDCA prophylaxis for patients commencing GLP-1 therapy, and such decisions should be made only following specialist consultation